USPTO serial 79450258
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific research apparatus and instruments intended for laboratories for analysis and reporting regarding pathology specimens in relation to the following fields: oncology; laboratory robots with artificial intelligence for scientific research in the field of oncology; recorded software for diagnostic support in relation to the following fields: oncology; recorded software for medical imaging analysis in relation to the following fields: oncology; computer programs and software enabling health status diagnosis, prescription of treatments and prescriptions, design of clinical trials and prediction of clinical trial outcomes, search for clinical trial participants, analysis of medical images, data analysis and development of pharmaceutical products and chemical compounds. | ACTIVE | — |
| 042 | Scientific, technological and medical research services in the field of oncology; scientific-technological services, namely, clinical trial design, data analysis, projection of clinical trial results, and therapeutic decision support, in the field of oncology; online provision of non-downloadable software for diagnostic support in the field of oncology; online provision of non-downloadable software for medical imaging analysis in the field of oncology; Software as a Service (SaaS) services featuring software for diagnostic support in the field of oncology; Software as a Service (SaaS) services featuring software for medical imaging analysis in the field of oncology; Software as a Service [SaaS] enabling health status analysis, prescription of treatments and prescriptions, design of clinical trials and prediction of clinical trial outcomes, search for clinical trial participants, analysis of medical images, data analysis and development of pharmaceutical products and chemical compounds. | ACTIVE | — |
| 044 | Medical services; medical diagnosis services; information and advisory services relating to pharmaceutical products; medical services in the field of oncology. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 23, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 23, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 17, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 18, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 17, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 5, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 5, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 21, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |